Compare Infosys Limited (INFY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Infosys Limited vs Twist Bioscience Corp — how do they compare? Infosys Limited trades at $12.42 (market cap $50.55B), while Twist Bioscience Corp trades at $123 (market cap $7.72B). The key difference: Infosys Limited is far larger — about 6.5× Twist Bioscience Corp's market cap, and Infosys Limited pays a 4.16% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| INFY | TWST | |
|---|---|---|
Market Cap | $50.55B | $7.72B |
Sector | Technology | Health |
52-Week High | $20.22 | $124.88 |
52-Week Low | $10.49 | $24.16 |
Enterprise Value | $48.30B | $7.65B |
Dividend Yield | 4.16% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
